Expansion Opportunities PharmaLogic is rapidly expanding its radiopharmaceutical manufacturing footprint with new facilities in Idaho Falls, Atlanta, Bronx, Cincinnati, Salt Lake City, and Los Angeles, indicating increased capacity needs and potential multi-site supply chain partnerships for clinical and commercial radiopharmaceuticals.

Strategic Partnerships Recent collaborations with Ratio Therapeutics and the broader emphasis on strategic development partnerships suggest strong interest in co-development and manufacturing arrangements for radiopharmaceuticals, presenting avenues for joint programs and capacity-backed deals.

Global Reach With a network spanning the US, Puerto Rico, Canada, and Norway, PharmaLogic offers international distribution capabilities that can support global market entry plans, regulatory readiness, and cross-border supply agreements for radiopharmaceutical products.

Commercial Readiness As the world’s only cGMP-compliant CDMO producing and distributing a commercial radiopharmaceutical therapy in over 30 countries, PharmaLogic demonstrates scale and regulatory maturity, making it a strong partner for manufacturers seeking reliable commercial-grade manufacturing and distribution.

Financial Scale Revenue in the mid-range of a few hundred million dollars and a sizable employee base indicate substantial operating capacity and potential for large, multi-year CDMO contracts, including capacity guarantees, supply security, and tiered pricing models for radiopharmaceuticals.